Literature DB >> 18206577

International Olympic Committee consensus statement: molecular basis of connective tissue and muscle injuries in sport.

Arne Ljungqvist1, Martin P Schwellnus, Norbert Bachl, Malcolm Collins, J Cook, K M Khan, Nicola Maffulli, Y Pitsiladis, G Riley, G Golspink, D Venter, E W Derman, L Engebretsen, P Volpi.   

Abstract

Tendon and ligament injures cause significant loss of performance in sport and decreased functional capacity in the workplace. Many of these injures remain difficult to treat, and many individuals have long-term pain and discomfort. Animal studies of growth factor and cell-based therapies have shown promising results, but these treatments also can be misused to enhance athletic performance. The International Olympic Committee (IOC) now has high-level scientific advisors who can advise the IOC as to the use and abuse of these technologies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18206577     DOI: 10.1016/j.csm.2007.10.007

Source DB:  PubMed          Journal:  Clin Sports Med        ISSN: 0278-5919            Impact factor:   2.182


  11 in total

1.  The cell biology of suturing tendons.

Authors:  J K F Wong; S Alyouha; K E Kadler; M W J Ferguson; D A McGrouther
Journal:  Matrix Biol       Date:  2010-06-21       Impact factor: 11.583

2.  Co-transfection of decorin and interleukin-10 modulates pro-fibrotic extracellular matrix gene expression in human tenocyte culture.

Authors:  Sunny A Abbah; Dilip Thomas; Shane Browne; Timothy O'Brien; Abhay Pandit; Dimitrios I Zeugolis
Journal:  Sci Rep       Date:  2016-02-10       Impact factor: 4.379

3.  Tendinopathies and platelet-rich plasma (PRP): from pre-clinical experiments to therapeutic use.

Authors:  Jean-François Kaux; Pierre Drion; Jean-Louis Croisier; Jean-Michel Crielaard
Journal:  J Stem Cells Regen Med       Date:  2015-05-30

4.  Semantic interrogation of a multi knowledge domain ontological model of tendinopathy identifies four strong candidate risk genes.

Authors:  Colleen J Saunders; Mahjoubeh Jalali Sefid Dashti; Junaid Gamieldien
Journal:  Sci Rep       Date:  2016-01-25       Impact factor: 4.379

Review 5.  Concise Review: Stem Cell Fate Guided By Bioactive Molecules for Tendon Regeneration.

Authors:  Yan-Jie Zhang; Xiao Chen; Gang Li; Kai-Ming Chan; Boon Chin Heng; Zi Yin; Hong-Wei Ouyang
Journal:  Stem Cells Transl Med       Date:  2018-03-23       Impact factor: 6.940

6.  The application of human periodontal ligament stem cells and biomimetic silk scaffold for in situ tendon regeneration.

Authors:  Jialin Chen; Qingyun Mo; Renwang Sheng; Aijing Zhu; Chen Ling; Yifan Luo; Aini Zhang; Zhixuan Chen; Qingqiang Yao; Zhuoying Cai; Wei Zhang
Journal:  Stem Cell Res Ther       Date:  2021-12-04       Impact factor: 6.832

Review 7.  Comparison of Tendon Development Versus Tendon Healing and Regeneration.

Authors:  Peiwen He; Dengfeng Ruan; Zizhan Huang; Canlong Wang; Yiwen Xu; Honglu Cai; Hengzhi Liu; Yang Fei; Boon Chin Heng; Weishan Chen; Weiliang Shen
Journal:  Front Cell Dev Biol       Date:  2022-01-24

Review 8.  Recent Applications of Electrospun Nanofibrous Scaffold in Tissue Engineering.

Authors:  Hamza Abu Owida; Jamal I Al-Nabulsi; Feras Alnaimat; Muhammad Al-Ayyad; Nidal M Turab; Ashraf Al Sharah; Murad Shakur
Journal:  Appl Bionics Biomech       Date:  2022-02-09       Impact factor: 1.781

9.  Fascial tissue research in sports medicine: from molecules to tissue adaptation, injury and diagnostics: consensus statement.

Authors:  Robert Schleip; Paul William Hodges; Martina Zügel; Constantinos N Maganaris; Jan Wilke; Karin Jurkat-Rott; Werner Klingler; Scott C Wearing; Thomas Findley; Mary F Barbe; Jürgen Michael Steinacker; Andry Vleeming; Wilhelm Bloch
Journal:  Br J Sports Med       Date:  2018-08-02       Impact factor: 13.800

10.  Defining the molecular signatures of Achilles tendinopathy and anterior cruciate ligament ruptures: A whole-exome sequencing approach.

Authors:  Andrea Gibbon; Colleen J Saunders; Malcolm Collins; Junaid Gamieldien; Alison V September
Journal:  PLoS One       Date:  2018-10-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.